BiotechTube
Home/Alzheon/Martin Tolar
MT

Martin Tolar

Founder, President, CEO, and Chairman

Alzheon

Therapeutic Areas

Alzheimer's DiseaseNeurodegenerative Disorders

Alzheon Pipeline

DrugIndicationPhase
Valiltramiprosate (ALZ-801)Early Symptomatic Alzheimer's Disease (APOE4/4 Homozygotes)Phase 3